Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection

World Journal of Gastroenterology

Volumn 22, Issue 2, 2016, Pages 567-581

  Mattar, Rafif E ^a   Al Alem, Faisal ^a   Simoneau, Eve ^b   Hassanain, Mazen ^a,c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Colorectal cancer liver metastases; Hepatectomy; Liver resection; Patient selection; Preoperative selection

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER CHEMOTHERAPY; CANCER PROGNOSIS; COLORECTAL LIVER METASTASIS; CONTRAST ENHANCEMENT; FUTURE LIVER REMNANT; HUMAN; LIVER FAILURE; LIVER RESECTION; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PHYSICAL PARAMETERS; PORTAL HYPERTENSION; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; REVIEW; ADJUVANT CHEMOTHERAPY; ADVERSE EFFECTS; COLON RESECTION; COLORECTAL NEOPLASMS; DECISION SUPPORT SYSTEM; DIAGNOSTIC IMAGING; LIVER NEOPLASMS; METASTASIS RESECTION; NEOADJUVANT THERAPY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; SECONDARY; TIME TO TREATMENT; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLORECTAL NEOPLASMS; DECISION SUPPORT TECHNIQUES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; METASTASECTOMY; NEOADJUVANT THERAPY; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84954435311     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i2.567     Document Type: Review

References (181)

1. Cady B. Basic principles in surgical oncology. Arch Surg 1997; 132: 338-346 [PMID: 9108752 DOI: 10.1001/archsurg.1997.01430280012001]
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30 [PMID: 23335087 DOI: 10.3322/caac.21166]
3. Al-Eid HS, Bazarbashi S, Al-Zahrani A. Cancer Incidence Report Saudi Arabia 2010. April 2014 ed. Saudi Cancer Registry, 2014. Available from: URL: http://www.chs.gov.sa/Ar/mediacenter/NewsLetter/2010 Report (1).pdf
4. Pestana C, Reitemeier RJ, Moertel CG, Judd ES, Dockerty MB. The Natural History of Carcinoma of the Colon and Rectum. Am J Surg 1964; 108: 826-829 [PMID: 14233766 DOI: 10.1016/0002-9 610(64)90041-8]
5. Weiss L, Grundmann E, Torhorst J, Hartveit F, Moberg I, Eder M, Fenoglio-Preiser CM, Napier J, Horne CH, Lopez MJ. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986; 150: 195-203 [PMID: 3806280 DOI: 10.1002/path.1711500308]
6. Hugh TJ, Kinsella AR, Poston GJ. Management strategies for colorectal liver metastases-Part I. Surg Oncol 1997; 6: 19-30 [PMID: 9364658 DOI: 10.1016/s0960-7404(97)00002-9]
7. Hugh TJ, Kinsella AR, Poston GJ. Management strategies for colorectal liver metastases-Part II. Surg Oncol 1997; 6: 31-48 [PMID: 9364659 DOI: 10.1016/s0960-7404(97)00003-0]
8. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006; 244: 254-259 [PMID: 16858188 DOI: 10.1097/01.sla.0000217629.94941.cf]
9. Choti MA, Sitzmann J V, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-766 [PMID: 12035031 DOI: 10.1097/00000658-200206000-00002]
10. Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, Kopetz S, Garrett C, Curley SA, Abdalla EK. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 2010; 210: 934-941 [PMID: 20510802 DOI: 10.1016/j.jamcollsurg.2010.02.039]
11. Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, Andreou A, Loyer EM, Madoff DC, Curley SA, Vauthey JN. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection defne outcome. J Clin Oncol 2011; 29: 1083-1090 [PMID: 21263087 DOI: 10.1200/JCO.2010.32.6132]
12. Adson MA. Resection of liver metastases-when is it worthwhile? World J Surg 1987; 11: 511-520 [PMID: 3630196 DOI: 10.1007/bf01655817]
13. Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 2005; 23: 8490-8499 [PMID: 16230676 DOI: 10.1200/JCO.2004.00.6155]
14. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, Maclean BJ, Foster JH, Daly JM, Fitzherbert D. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986; 100: 278-284 [PMID: 3526605]
15. Höhn HG. Anhang. Operationskatalog für Betriebsvergleiche (Seiten 134-146). Krankenhausumschau 1985; 2: 134-146 [DOI: 10.1007/978-3-642-70126-9-4]
16. Yamamoto K, Fukumori D, Yamamoto F, Yamamoto M, Igimi H, Yamashita Y. First report of hepatectomy without endotracheal general anesthesia. J Am Coll Surg 2013; 216: 908-914 [PMID: 23490541 DOI: 10.1016/j.jamcollsurg.2013.01.002]
17. Liu S, Carpenter RL, Neal JM. Epidural anesthesia and analgesia. Their role in postoperative outcome. Anesthesiology 1995; 82: 1474-1506 [PMID: 7793661 DOI: 10.1097/00000542-199506000-00019]
18. Buell JF. Laparoscopic hepatectomy under epidural anesthesia without general endotracheal anesthesia: feasible but applicable? Ann Surg 2014; 260: e2 [PMID: 25350652 DOI: 10.1097/SLA.0000000000000815]
19. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH. Improvement in perioperative outcome after hepatic resection: analysis of 1, 803 consecutive cases over the past decade. Ann Surg 2002; 236: 397-406; discussion 406-7 [PMID: 12368667 DOI: 10.1097/01. SLA.0000029003.66466.B3]
20. Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, Dematteo RP, Tuorto S, Wuest D, Blumgart LH, Fong Y. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003; 237: 860-869; discussion 869-870 [PMID: 12796583 DOI: 10.1097/01.SLA.0000072371.95588.DA]
21. Smyrniotis V, Kostopanagiotou G, Theodoraki K, Tsantoulas D, Contis JC. The role of central venous pressure and type of vascular control in blood loss during major liver resections. Am J Surg 2004; 187: 398-402 [PMID: 15006570 DOI: 10.1016/j.amjsurg.2003.12.001]
22. Johnson M, Mannar R, Wu AV. Correlation between blood loss and inferior vena caval pressure during liver resection. Br J Surg 1998; 85: 188-190 [PMID: 9501812 DOI: 10.1046/j.1365-2168.1998.00570. x]
23. Sear JW. Kidney dysfunction in the postoperative period. Br J Anaesth 2005; 95: 20-32 [PMID: 15531622 DOI: 10.1093/bja/aei018]
24. Correa-Gallego C, Berman A, Denis SC, Langdon-Embry L, O' Connor D, Arslan-Carlon V, Kingham TP, D'Angelica MI, Allen PJ, Fong Y, DeMatteo RP, Jarnagin WR, Melendez J, Fischer M. Renal function after low central venous pressure-assisted liver resection: assessment of 2116 cases. HPB (Oxford) 2015; 17: 258-264 [PMID: 25387727 DOI: 10.1111/hpb.12347]
25. Virani S, Michaelson JS, Hutter MM, Lancaster RT, Warshaw AL, Henderson WG, Khuri SF, Tanabe KK. Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg 2007; 204: 1284-1292 [PMID: 17544086 DOI: 10.1016/j.jamcollsurg.2007.02.067]
26. Friedman LS. Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc 2010; 121: 192-204; discussion 205 [PMID: 20697561]
27. Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e227S-e277S [PMID: 22315263 DOI: 10.1378/chest.11-2297]
28. Strasberg SM, Hall BL. Postoperative morbidity index: a quantitative measure of severity of postoperative complications. J Am Coll Surg 2011; 213: 616-626 [PMID: 21871822 DOI: 10.1016/j.jamcollsurg.2011.07.019]
29. Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, Curley SA, Vauthey JN, Aloia TA. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford) 2012; 14: 506-513 [PMID: 22762398 DOI: 10.1111/j.1477-2574.2012.00479.x]
30. Ishizawa T, Gumbs AA, Kokudo N, Gayet B. Laparoscopic segmentectomy of the liver: from segment I to VIII. Ann Surg 2012; 256: 959-964 [PMID: 22968066 DOI: 10.1097/SLA.0b013e31825ffed3]
31. Belli G, Fantini C, D'Agostino A, Cioff L, Langella S, Russolillo N, Belli A. Laparoscopic versus open liver resection for hepatocellular carcinoma in patients with histologically proven cirrhosis: short-and middle-term results. Surg Endosc 2007; 21: 2004-2011 [PMID: 17705086 DOI: 10.1007/s00464-007-9503-6]
32. Montalti R, Berardi G, Laurent S, Sebastiani S, Ferdinande L, Libbrecht LJ, Smeets P, Brescia A, Rogiers X, de Hemptinne B, Geboes K, Troisi RI. Laparoscopic liver resection compared to open approach in patients with colorectal liver metastases improves further resectability: Oncological outcomes of a case-control matched-pairs analysis. Eur J Surg Oncol 2014; 40: 536-544 [PMID: 24555996 DOI: 10.1016/j.ejso.2014.01.005]
33. Dagher I, Di Giuro G, Dubrez J, Lainas P, Smadja C, Franco D. Laparoscopic versus open right hepatectomy: a comparative study. Am J Surg 2009; 198: 173-177 [PMID: 19268902 DOI: 10.1016/j.amjsurg.2008.09.015]
34. Farges O, Goutte N, Bendersky N, Falissard B. Incidence and risks of liver resection: an all-inclusive French nationwide study. Ann Surg 2012; 256: 697-704; discussion 704-705 [PMID: 23095612 DOI: 10.1097/SLA.0b013e31827241d5]
35. Al-Refaie WB, Parsons HM, Henderson WG, Jensen EH, Tuttle TM, Vickers SM, Rothenberger DA, Virnig BA. Major cancer surgery in the elderly: results from the American College of Surgeons National Surgical Quality Improvement Program. Ann Surg 2010; 251: 311-318 [PMID: 19838107 DOI: 10.1097/SLA.0b013e3181b6b04c]
36. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318; discussion 318-321 [PMID: 10493478 DOI: 10.1097/00000658-199909000-00004]
37. Tsujita E, Utsunomiya T, Yamashita Y, Ohta M, Tagawa T, Matsuyama A, Okazaki J, Yamamoto M, Tsutsui S, Ishida T. Outcome of hepatectomy in hepatocellular carcinoma patients aged 80 years and older. Hepatogastroenterology 2012; 59: 1553-1555 [PMID: 22683972 DOI: 10.5754/hge09485]
38. Tzeng CW, Cooper AB, Vauthey JN, Curley SA, Aloia TA. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford) 2014; 16: 459-468 [PMID: 24033514 DOI: 10.1111/hpb.12155]
39. Uwatoko S, Yamamoto K, Sasaki T, Fukumori D, Igimi H, Yamamoto M, Yamamoto F, Yamashita Y. Age is no longer a limit: two cases of hepatectomy in patients over 90 years old. Case Rep Gastroenterol 2015; 9: 49-55 [PMID: 25802498 DOI: 10.1159/000368115]
40. Inoue Y, Hayashi M, Komeda K, Masubuchi S, Yamamoto M, Yamana H, Kayano H, Shimizu T, Asakuma M, Hirokawa F, Miyamoto Y, Takeshita A, Shibayama Y, Uchiyama K. Resection margin with anatomic or nonanatomic hepatectomy for liver metastasis from colorectal cancer. J Gastrointest Surg 2012; 16: 1171-1180 [PMID: 22370732 DOI: 10.1007/s11605-012-1840-7]
41. Read JA, Choy ST, Beale PJ, Clarke SJ. Evaluation of nutritional and infammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer 2006; 55: 78-85 [PMID: 16965244 DOI: 10.1207/s15327914nc5501-10]
42. Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006; 13: 1261-1268 [PMID: 16947009 DOI: 10.1245/s10434-006-9023-y]
43. Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) 2013; 15: 91-103 [PMID: 23297719 DOI: 10.1111/j.1477-2574.2012.00557.x]
44. Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, Ledermann J, Primrose JN, Parks RW. Guidelines for resection of colorectal cancer liver metastases. Gut 2006; 55 Suppl 3: iii1-iii8 [PMID: 16835351 DOI: 10.1136/gut.2006.098053]
45. Kamel IR, Fishman EK. Recent advances in CT imaging of liver metastases. Cancer J 2004; 10: 104-120 [PMID: 15130270 DOI: 10.1097/00130404-200403000-00006]
46. Ward BA, Miller DL, Frank JA, Dwyer AJ, Simmons JT, Chang R, Shawker TH, Choyke P, Chang AE. Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: correlation with surgical findings. Surgery 1989; 105: 180-187 [PMID: 2536965]
47. Khalil HI, Patterson SA, Panicek DM. Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology 2005; 235: 872-878 [PMID: 15833992 DOI: 10.1148/radiol.2353041099]
48. Wiggans MG, Shahtahmassebi G, Aroori S, Bowles MJ, Jackson SA, Stell DA. Assessment of the value of MRI scan in addition to CT in the pre-operative staging of colorectal liver metastases. J Gastrointest Cancer 2014; 45: 146-153 [PMID: 24408271 DOI: 10.1007/s12029-013-9569-4]
49. Kulemann V, Schima W, Tamandl D, Kaczirek K, Gruenberger T, Wrba F, Weber M, Ba-Ssalamah A. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur J Radiol 2011; 79: e1-e6 [PMID: 20392584 DOI: 10.1016/j.ejrad.2010.03.004]
50. Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, Coleman RE, Wahl R, Paschold JC, Avril N, Einhorn LH, Suh WW, Samson D, Delbeke D, Gorman M, Shields AF. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008; 49: 480-508 [PMID: 18287273 DOI: 10.2967/jnumed.107.047787]
51. Maffone AM, Lopci E, Bluemel C, Giammarile F, Herrmann K, Rubello D. Diagnostic accuracy and impact on management of (18)F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review. Eur J Nucl Med Mol Imaging 2015; 42: 152-163 [PMID: 25319712 DOI: 10.1007/s00259-014-2930-4]
52. Erturk SM, Ichikawa T, Fujii H, Yasuda S, Ros PR. PET imaging for evaluation of metastatic colorectal cancer of the liver. Eur J Radiol 2006; 58: 229-235 [PMID: 16457980 DOI: 10.1016/j.ejrad.2005.11.042]
53. Moulton CA, Gu CS, Law CH, Tandan VR, Hart R, Quan D, Fairfull Smith RJ, Jalink DW, Husien M, Serrano PE, Hendler AL, Haider MA, Ruo L, Gulenchyn KY, Finch T, Julian JA, Levine MN, Gallinger S. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial. JAMA 2014; 311: 1863-1869 [PMID: 24825641 DOI: 10.1001/jama.2014.3740]
54. Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, Stoker J. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 2005; 237: 123-131 [PMID: 16100087 DOI: 10.1148/radiol.2371042060]
55. Bonanni L, De'liguori Carino N, Deshpande R, Ammori BJ, Sherlock DJ, Valle JW, Tam E, O'Reilly DA. A comparison of diagnostic imaging modalities for colorectal liver metastases. Eur J Surg Oncol 2014; 40: 545-550 [PMID: 24491289 DOI: 10.1016/j.ejso.2013.12.023]
56. Cantisani V, Grazhdani H, Fioravanti C, Rosignuolo M, Calliada F, Messineo D, Bernieri MG, Redler A, Catalano C, D'Ambrosio F. Liver metastases: Contrast-enhanced ultrasound compared with computed tomography and magnetic resonance. World J Gastroenterol 2014; 20: 9998-10007 [PMID: 25110428 DOI: 10.3748/wjg.v20.i29.9998]
57. Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, Piscaglia F, Wilson SR, Barr RG, Chammas MC, Chaubal NG, Chen MH, Clevert DA, Correas JM, Ding H, Forsberg F, Fowlkes JB, Gibson RN, Goldberg BB, Lassau N, Leen EL, Mattrey RF, Moriyasu F, Solbiati L, Weskott HP, Xu HX. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver-update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013; 39: 187-210 [PMID: 23137926 DOI: 10.1016/j.ultrasm edbio.2012.09.002]
58. Arita J, Ono Y, Takahashi M, Inoue Y, Takahashi Y, Saiura A. Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy. Ann Surg Oncol 2014; 21 Suppl 3: S390-S397 [PMID: 24570378 DOI: 10.1245/s10434-014-3576-y]
59. Torzilli G, Botea F, Donadon M, Cimino M, Procopio F, Pedicini V, Poretti D, Montorsi M. Criteria for the selective use of contrast-enhanced intra-operative ultrasound during surgery for colorectal liver metastases. HPB (Oxford) 2014; 16: 994-1001 [PMID: 24830573 DOI: 10.1111/hpb.12272]
60. Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hägerstrand I, Ranstam J, Bengmark S. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986; 73: 727-731 [PMID: 3756436 DOI: 10.1002/bjs.1800730917]
61. van Dam RM, Lodewick TM, van den Broek MA, de Jong MC, Greve JW, Jansen RL, Bemelmans MH, Neumann UP, Olde Damink SW, Dejong CH. Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases. HPB (Oxford) 2014; 16: 550-559 [PMID: 24246003 DOI: 10.1111/hpb.12181]
62. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008; 13: 51-64 [PMID: 18245012 DOI: 10.1634/theoncologist.2007-0142]
63. Dhir M, Lyden ER, Wang A, Smith LM, Ullrich F, Are C. Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis. Ann Surg 2011; 254: 234-242 [PMID: 21694583 DOI: 10.1097/SLA.0b013e318223c609]
64. Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, Yamamoto J, Yamaguchi T, Muto T, Makuuchi M. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg 2002; 137: 833-840 [PMID: 12093342 DOI: 10.1001/archsurg.137.7.833]
65. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, Matsubara T, Takahashi T, Nakajima T, Muto T. Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 2001; 181: 153-159 [PMID: 11425058 DOI: 10.1016/s0002-9610(00)00560-2]
66. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241: 715-722, discussion 722-724 [PMID: 15849507 DOI: 10.1097/01.sla.0000160703.75808.7d]
67. Scheele J, Altendorf-Hofmann A, Grube T, Hohenberger W, Stangl R, Schmidt K. [Resection of colorectal liver metastases. What prognostic factors determine patient selection?]. Chirurg 2001; 72: 547-560 [PMID: 11383067 DOI: 10.1007/s001040051345]
68. Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W, Starzl TE. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994; 116: 703-710; discussion 710-711 [PMID: 7940169]
69. Suzuki S, Sakaguchi T, Yokoi Y, Kurachi K, Okamoto K, Okumura T, Tsuchiya Y, Nakamura T, Konno H, Baba S, Nakamura S. Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery 2001; 129: 421-428 [PMID: 11283532 DOI: 10.1067/msy.2001.112486]
70. Nakamura S, Suzuki S, Konno H. Resection of hepatic metastases of colorectal carcinoma: 20 years' experience. J Hepatobiliary Pancreat Surg 1999; 6: 16-22 [PMID: 10436233 DOI: 10.1007/s005340050079]
71. Assumpcao L, Choti MA, Gleisner AL, Schulick RD, Swartz M, Herman J, Gearhart SL, Pawlik TM. Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site. Arch Surg 2008; 143: 743-749; discussion 749-750 [PMID: 18711033 DOI: 10.1001/archsurg.143.8.743]
72. Malafosse R, Penna C, Sa Cunha A, Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 2001; 12: 887-894 [PMID: 11521792]
73. Kubo M, Sakamoto M, Fukushima N, Yachida S, Nakanishi Y, Shimoda T, Yamamoto J, Moriya Y, Hirohashi S. Less aggressive features of colorectal cancer with liver metastases showing macroscopic intrabiliary extension. Pathol Int 2002; 52: 514-518 [PMID: 12366810 DOI: 10.1046/j.1440-1827.2002.01382.x]
74. Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN. Hepatic insuffciency and mortality in 1, 059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007; 204: 854-862; discussion 862-864 [PMID: 17481498 DOI: 10.1016/j.jamcollsurg.2006.12.032]
75. Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey JN. Total and segmental liver volume variations: implications for liver surgery. Surgery 2004; 135: 404-410 [PMID: 15041964 DOI: 10.1016/j.surg.2003.08.024]
76. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001; 88: 165-175 [PMID: 11167863 DOI: 10.1046/j.1365-2168.2001.01658. x]
77. Vauthey JN, Pawlik TM, Abdalla EK, Arens JF, Nemr RA, Wei SH, Kennamer DL, Ellis LM, Curley SA. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 2004; 239: 722-30; discussion 730-2 [PMID: 15082977 DOI: 10.1097/01. sla.0000124385.83887.d5]
78. Henderson JM, Heymsfield SB, Horowitz J, Kutner MH. Measurement of liver and spleen volume by computed tomography. Assessment of reproducibility and changes found following a selective distal splenorenal shunt. Radiology 1981; 141: 525-527 [PMID: 6974875 DOI: 10.1148/radiology.141.2.6974875]
79. Soyer P, Roche A, Elias D, Levesque M. Hepatic metastases from colorectal cancer: influence of hepatic volumetric analysis on surgical decision making. Radiology 1992; 184: 695-697 [PMID: 1509051 DOI: 10.1148/radiology.184.3.1509051]
80. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007; 94: 1386-1394 [PMID: 17583900 DOI: 10.1002/bjs.5836]
81. Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 2005; 12: 16-22 [PMID: 15754094 DOI: 10.1007/s00534-004-0965-9]
82. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 1996; 77: 1254-1262 [PMID: 8608500]
83. Gotohda N, Iwagaki H, Ozaki M, Kinoshita T, Konishi M, Nakagohri T, Takahashi S, Saito S, Yagi T, Tanaka N. Deficient response of IL-6 impaired liver regeneration after hepatectomy in patients with viral hepatitis. Hepatogastroenterology 2008; 55: 1439-1444 [PMID: 18795707]
84. Neal CP, Mann CD, Pointen E, McGregor A, Garcea G, Metcalfe MS, Berry DP, Dennison AR. Influence of hepatic parenchymal histology on outcome following right hepatic trisectionectomy. J Gastrointest Surg 2012; 16: 2064-2073 [PMID: 22923210 DOI: 10.1007/s11605-012-2008-1]
85. Reddy SK, Marsh JW, Varley PR, Mock BK, Chopra KB, Geller DA, Tsung A. Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study. Hepatology 2012; 56: 2221-2230 [PMID: 22767263 DOI: 10.1002/hep.25935]
86. Veteläinen R, van Vliet AK, van Gulik TM. Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy. Ann Surg 2007; 245: 44-50 [PMID: 17197964 DOI: 10.1097/01.sla.0000225253.84501.0e]
87. Cauchy F, Fuks D, Zarzavadjian Le Bian A, Belghiti J, Costi R. Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges? World J Hepatol 2014; 6: 306-314 [PMID: 24868324 DOI: 10.4254/wjh.v6.i5.306]
88. Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010; 362: 1675-1685 [PMID: 20427778 DOI: 10.1056/NEJMoa0907929]
89. Marsman HA, de Graaf W, Heger M, van Golen RF, Ten Kate FJ, Bennink R, van Gulik TM. Hepatic regeneration and functional recovery following partial liver resection in an experimental model of hepatic steatosis treated with omega-3 fatty acids. Br J Surg 2013; 100: 674-683 [PMID: 23456631 DOI: 10.1002/bjs.9059]
90. Hassanain M, Metrakos P, Fisette A, Doi SA, Schricker T, Lattermann R, Carvalho G, Wykes L, Molla H, Cianflone K. Randomized clinical trial of the impact of insulin therapy on liver function in patients undergoing major liver resection. Br J Surg 2013; 100: 610-618 [PMID: 23339047 DOI: 10.1002/bjs.9034]
91. Fisette A, Hassanain M, Metrakos P, Doi SA, Salman A, Schricker T, Lattermann R, Wykes L, Nitschmann E, Smith J, Cianfone K. High-dose insulin therapy reduces postoperative liver dysfunction and complications in liver resection patients through reduced apoptosis and altered infammation. J Clin Endocrinol Metab 2012; 97: 217-226 [PMID: 22031518 DOI: 10.1210/jc.2011-1598]
92. Iascone C, Ruperto M, Barillari P. [Occurrence of synchronous colorectal cancer metastasis in the cirrhotic or fatty liver]. Minerva Chir 2005; 60: 185-190 [PMID: 15985994]
93. Ramia JM, López-Andujar R, Torras J, Falgueras L, Gonzalez JA, Sanchez B, Figueras J. Multicentre study of liver metastases from colorectal cancer in pathological livers. HPB (Oxford) 2011; 13: 320-323 [PMID: 21492331 DOI: 10.1111/j.1477-2574.2010.00287. x]
94. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-1440 [PMID: 10573522 DOI: 10.1002/hep.510300629]
95. Azoulay D, Castaing D, Krissat J, Smail A, Hargreaves GM, Lemoine A, Emile JF, Bismuth H. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 2000; 232: 665-672 [PMID: 11066138 DOI: 10.1097/00000658-20 0011000-00008]
96. Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 2006; 93: 1091-1098 [PMID: 16779884 DOI: 10.1002/bjs.5341]
97. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Visa J, Bru C, Rodés J. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996; 111: 1018-1022 [PMID: 8831597 DOI: 10.1016/S0016-5085(96)70070-7]
98. Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 2006; 93: 465-474 [PMID: 16523446 DOI: 10.1002/bjs.5278]
99. Ballantyne GH, Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993; 71: 4252-4266 [PMID: 8508388 DOI: 10.1002/1097-0142(19930615)71:12]
100. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110: 13-29 [PMID: 1866690]
101. Bockhorn M, Frilling A, Frühauf NR, Neuhaus J, Molmenti E, Trarbach T, Malagó M, Lang H, Broelsch CE. Survival of patients with synchronous and metachronous colorectal liver metastases-is there a difference? J Gastrointest Surg 2008; 12: 1399-1405 [PMID: 18521698 DOI: 10.1007/s11605-008-0508-9]
102. Bova R, Kamphues C, Neuhaus P, Puhl G. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients]. Zentralbl Chir 2014; 139: 220-225 [PMID: 23846535 DOI: 10.1055/s-0032-1328568]
103. Vassiliou I, Arkadopoulos N, Theodosopoulos T, Fragulidis G, Marinis A, Kondi-Paphiti A, Samanides L, Polydorou A, Gennatas C, Voros D, Smyrniotis V. Surgical approaches of resectable synchronous colorectal liver metastases: timing considerations. World J Gastroenterol 2007; 13: 1431-1434 [PMID: 17457976 DOI: 10.3748/wjg.v13.i9.1431]
104. Jegatheeswaran S, Mason JM, Hancock HC, Siriwardena AK. The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review. JAMA Surg 2013; 148: 385-391 [PMID: 23715907 DOI: 10.1001/jamasurg.2013.1216]
105. Patrlj L, Kopljar M, Klicek R, Patrlj MH, Kolovrat M, Rakic M, Duzel A. The surgical treatment of patients with colorectal cancer and liver metastases in the setting of the "liver first" approach. Hepatobiliary Surg Nutr 2014; 3: 324-329 [PMID: 25392845 DOI: 10.3978/j.issn.2304-3881.2014.09.12]
106. Verhoef C, van der Pool AE, Nuyttens JJ, Planting AS, Eggermont AM, de Wilt JH. The "liver-frst approach" for patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum 2009; 52: 23-30 [PMID: 19273952 DOI: 10.1007/DCR.0b013e318197939a]
107. Andres A, Toso C, Adam R, Barroso E, Hubert C, Capussotti L, Gerstel E, Roth A, Majno PE, Mentha G. A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study. Ann Surg 2012; 256: 772-778; discussion 778-779 [PMID: 23095621 DOI: 10.1097/SLA.0b013e3182734423]
108. Kelly ME, Spolverato G, Lê GN, Mavros MN, Doyle F, Pawlik TM, Winter DC. Synchronous colorectal liver metastasis: a network meta-analysis review comparing classical, combined, and liver-first surgical strategies. J Surg Oncol 2015; 111: 341-351 [PMID: 25363294 DOI: 10.1002/jso.23819]
109. de Rosa A, Gomez D, Hossaini S, Duke K, Fenwick SW, Brooks A, Poston GJ, Malik HZ, Cameron IC. Stage IV colorectal cancer: outcomes following the liver-frst approach. J Surg Oncol 2013; 108: 444-449 [PMID: 24009161 DOI: 10.1002/jso.23429]
110. Feng Q, Wei Y, Zhu D, Ye L, Lin Q, Li W, Qin X, Lyu M, Xu J. Timing of hepatectomy for resectable synchronous colorectal liver metastases: for whom simultaneous resection is more suitable-A meta-analysis. PLoS One 2014; 9: e104348 [PMID: 25093337 DOI: 10.1371/journal.pone.0104348]
111. Yin Z, Liu C, Chen Y, Bai Y, Shang C, Yin R, Yin D, Wang J. Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): Simultaneous or delayed? Hepatology 2013; 57: 2346-2357 [PMID: 23359206 DOI: 10.1002/hep.26283]
112. Jenkins LT, Millikan KW, Bines SD, Staren ED, Doolas A. Hepatic resection for metastatic colorectal cancer. Am Surg 1997; 63: 605-610 [PMID: 9202534]
113. Kaibori M, Iwamoto S, Ishizaki M, Matsui K, Saito T, Yoshioka K, Hamada Y, Kwon AH. Timing of resection for synchronous liver metastases from colorectal cancer. Dig Dis Sci 2010; 55: 3262-3270 [PMID: 20112062 DOI: 10.1007/s10620-009-1124-6]
114. Weiss L, Voit A, Lane WW. Metastatic patterns in patients with carcinomas of the lower esophagus and upper rectum. Invasion Metastasis 1984; 4: 47-60 [PMID: 6735638]
115. Jones RP, Malik HZ, Fenwick SW, Poston GJ. Perioperative chemotherapy for resectable colorectal liver metastases: where now? Eur J Surg Oncol 2013; 39: 807-811 [PMID: 23726258 DOI: 10.1016/j.ejso.2013.04.002]
116. Pessaux P, Chenard MP, Bachellier P, Jaeck D. Consequences of chemotherapy on resection of colorectal liver metastases. J Visc Surg 2010; 147: e193-e201 [PMID: 20655821 DOI: 10.1016/j.jviscsurg.2010.06.004]
117. Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005; 23: 2038-2048 [PMID: 15774795 DOI: 10.1200/JCO.2005.00.349]
118. Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien PA. Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg 2012; 255: 237-247 [PMID: 22041509 DOI: 10.1097/SLA.0b013e3182356236]
119. Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, Brienza S, Alafaci E, Bertheault-Cvitkovic F, Jasmin C, Reynes M, Bismuth H, Misset JL, Lévi F. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999; 10: 663-669 [PMID: 10442188]
120. Goéré D, Deshaies I, de Baere T, Boige V, Malka D, Dumont F, Dromain C, Ducreux M, Elias D. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Ann Surg 2010; 251: 686-691 [PMID: 20224373 DOI: 10.1097/SLA.0b013e3181d35983]
121. Beppu T, Miyamoto Y, Sakamoto Y, Imai K, Nitta H, Hayashi H, Chikamoto A, Watanabe M, Ishiko T, Baba H. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival. Ann Surg Oncol 2014; 21 Suppl 3: S405-S413 [PMID: 24570379 DOI: 10.1245/s10434-014-3577-x]
122. Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Takiuchi H, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol 2012; 17: 1-29 [PMID: 22002491 DOI: 10.1007/s10147-011-0315-2]
123. Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003; 7: 109-115; discussion 116-117 [PMID: 12559192 DOI: 10.1016/s1091-255x(02)00121-x]
124. Sugihara K, Uetake H. Therapeutic strategies for hepatic metastasis of colorectal cancer: overview. J Hepatobiliary Pancreat Sci 2012; 19: 523-527 [PMID: 22706522 DOI: 10.1007/s00534-012-0524-8]
125. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-1016 [PMID: 18358928 DOI: 10.1016/S0140-6736(08)60455-9]
126. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004; 15: 460-466 [PMID: 14998849 DOI: 10.1093/annonc/mdh095]
127. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22: 27-42 [PMID: 11928077 DOI: 10.1055/s-2002-23204]
128. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24: 2065-2072 [PMID: 16648507 DOI: 10.1200/JCO.2005.05.3074]
129. Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, Bachellier P, Jaeck D. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008; 247: 118-124 [PMID: 18156931 DOI: 10.1097/SLA.0b013e31815774de]
130. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007; 94: 274-286 [PMID: 17315288 DOI: 10.1002/bjs.5719]
131. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, Rougier P, Nordlinger B. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243: 1-7 [PMID: 16371728 DOI: 10.1097/01. sla.0000193603.26265.c3]
132. Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, Chang DZ, Curley SA, Abdalla EK, Ellis LM, Vauthey JN. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 2007; 110: 2761-2767 [PMID: 17960603 DOI: 10.1002/cncr.23099]
133. Brouquet A, Benoist S, Julie C, Penna C, Beauchet A, Rougier P, Nordlinger B. Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases. Surgery 2009; 145: 362-371 [PMID: 19303984 DOI: 10.1016/j.surg.2008.12.002]
134. Panaro F, Casnedi S, Zeca I, Bachellier P, Chenard-Neu MP, Pessaux P. P.206 Conséquences cliniques, biologiques et histologiques du cetuximab et du bevacizumab après hépatectomie pour métastases d'origine colo-rectale: étude cas-témoin. Gastroentérologie Clinique et Biologique 2009; 33: A151 [DOI: 10.1016/s0399-8320(09)72897-0]
135. Satoh T, Gemma A, Kudoh S, Sakai F, Yamaguchi K, Watanabe T, Ishiguro M, Inoshiri S, Izawa M, Sugihara K, Sakata Y. Incidence and clinical features of drug-induced lung injury in patients with advanced colorectal cancer receiving cetuximab: results of a prospective multicenter registry. Jpn J Clin Oncol 2014; 44: 1032-1039 [PMID: 25210144 DOI: 10.1093/jjco/hyu128]
136. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998; 2: 292-298 [PMID: 9841987 DOI: 10.1016/s1091-255x(98)80025-5]
137. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005; 200: 845-853 [PMID: 15922194 DOI: 10.1016/j.jamcollsurg.2005.01.024]
138. Nigri G, Petrucciani N, Ferla F, La Torre M, Aurello P, Ramacciato G. Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies. Surgeon 2015; 13: 83-90 [PMID: 25257725 DOI: 10.1016/j.surge.2014.07.005]
139. Tanaka K, Adam R, Shimada H, Azoulay D, Lévi F, Bismuth H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 2003; 90: 963-969 [PMID: 12905549 DOI: 10.1002/bjs.4160]
140. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Mauer M, Tanis E, Van Cutsem E, Scheithauer W, Gruenberger T. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 2013; 14: 1208-1215 [PMID: 24120480 DOI: 10.1016/S1470-2045(13)70447-9]
141. Elias D, Ouellet JF, Bellon N, Pignon JP, Pocard M, Lasser P. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 2003; 90: 567-574 [PMID: 12734864 DOI: 10.1002/bjs.4071]
142. Hwang M, Jayakrishnan TT, Green DE, George B, Thomas JP, Groeschl RT, Erickson B, Pappas SG, Gamblin TC, Turaga KK. Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease. Eur J Cancer 2014; 50: 1747-1757 [PMID: 24767470 DOI: 10.1016/j.ejca.2014.03.277]
143. Galandiuk S, Wieand HS, Moertel CG, Cha SS, Fitzgibbons RJ, Pemberton JH, Wolff BG. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 1992; 174: 27-32 [PMID: 1729745]
144. Gonzalez M, Robert JH, Halkic N, Mentha G, Roth A, Perneger T, Ris HB, Gervaz P. Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases. World J Surg 2012; 36: 386-391 [PMID: 22167262 DOI: 10.1007/s00268-011-1381-3]
145. Limmer S, Oevermann E, Killaitis C, Kujath P, Hoffmann M, Bruch HP. Sequential surgical resection of hepatic and pulmonary metastases from colorectal cancer. Langenbecks Arch Surg 2010; 395: 1129-1138 [PMID: 20165954 DOI: 10.1007/s00423-010-0595-4]
146. Mise Y, Kopetz S, Mehran RJ, Aloia TA, Conrad C, Brudvik KW, Taggart MW, Vauthey JN. Is complete liver resection without resection of synchronous lung metastases justified? Ann Surg Oncol 2015; 22: 1585-1592 [PMID: 25373535 DOI: 10.1245/s10434-014-4207-3]
147. Andres A, Mentha G, Adam R, Gerstel E, Skipenko OG, Barroso E, Lopez-Ben S, Hubert C, Majno PE, Toso C. Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases. Br J Surg 2015; 102: 691-699 [PMID: 25789941 DOI: 10.1002/bjs.9783]
148. Henschke CI, McCauley DI, Yankelevitz DF, Naidich D P, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354: 99-105 [PMID: 10408484 DOI: 10.1016/s0140-6736(99)06093-6]
149. Maithel SK, Ginsberg MS, D'Amico F, DeMatteo RP, Allen PJ, Fong Y, Blumgart LH, Jarnagin WR, D'Angelica MI. Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer. J Am Coll Surg 2010; 210: 31-38 [PMID: 20123329 DOI: 10.1016/j.jamcollsurg.2009.09.032]
150. Quyn AJ, Matthews A, Daniel T, Amin AI, Yalamarthi S. The clinical significance of radiologically detected indeterminate pulmonary nodules in colorectal cancer. Colorectal Dis 2012; 14: 828-831 [PMID: 21762353 DOI: 10.1111/j.1463-1318.2011.02722. x]
151. Choi DJ, Kwak JM, Kim J, Woo SU, Kim SH. Preoperative chest computerized tomography in patients with locally advanced mid or lower rectal cancer: its role in staging and impact on treatment strategy. J Surg Oncol 2010; 102: 588-592 [PMID: 20607759 DOI: 10.1002/jso.21651]
152. Brent A, Talbot R, Coyne J, Nash G. Should indeterminate lung lesions reported on staging CT scans Influence the management of patients with colorectal cancer? Colorectal Dis 2007; 9: 816-818 [PMID: 17931171 DOI: 10.1111/j.1463-1318.2007.01229.x]
153. Downs-Canner S, Bahar R, Reddy SK, Cardinal JS, Marsh JW, Geller DA, Tsung A. Indeterminate pulmonary nodules represent lung metastases in a signifcant portion of patients undergoing liver resection for malignancy. J Gastrointest Surg 2012; 16: 2256-2259 [PMID: 23086449 DOI: 10.1007/s11605-012-2051-y]
154. Gomez D, Kamali D, Dunn WK, Beckingham IJ, Brooks A, Cameron IC. Outcomes in patients with indeterminate pulmonary nodules undergoing resection for colorectal liver metastases. HPB (Oxford) 2012; 14: 448-454 [PMID: 22672546 DOI: 10.1111/j.1477-2574.2012.00474.x]
155. Welter S, Jacobs J, Krbek T, Poettgen C, Stamatis G. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg 2007; 31: 167-172 [PMID: 17150367 DOI: 10.1016/j.ejcts.2006.11.004]
156. Adam R, de Haas RJ, Wicherts DA, Aloia TA, Delvart V, Azoulay D, Bismuth H, Castaing D. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol 2008; 26: 3672-3680 [PMID: 18669451 DOI: 10.1200/JCO.2007.15.7297]
157. Chua TC, Morris DL. Colorectal liver metastases with extrahepatic disease-A new criteria for oncologic resection? J Gastrointest Cancer 2012; 43: 502-504 [PMID: 21494785 DOI: 10.1007/s12029-011-9278-9]
158. Kianmanesh R, Scaringi S, Sabate JM, Castel B, Pons-Kerjean N, Coffn B, Hay JM, Flamant Y, Msika S. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 2007; 245: 597-603 [PMID: 17414609 DOI: 10.1097/01.sla.0000255561.87771.11]
159. Chua TC, Yan TD, Zhao J, Morris DL. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection. Eur J Surg Oncol 2009; 35: 1299-1305 [PMID: 19632081 DOI: 10.1016/j.ejso.2009.07.005]
160. Elias D, Benizri E, Pocard M, Ducreux M, Boige V, Lasser P. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol 2006; 32: 632-636 [PMID: 16621428 DOI: 10.1016/j.ejso.2006.03.013]
161. Pulitanò C, Bodingbauer M, Aldrighetti L, de Jong MC, Castillo F, Schulick RD, Parks RW, Choti MA, Wigmore SJ, Gruenberger T, Pawlik TM. Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol 2011; 18: 1380-1388 [PMID: 21136180 DOI: 10.1245/s10434-010-1459-4]
162. McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS. Evaluation of an infammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 2007; 22: 881-886 [PMID: 17245566 DOI: 10.1007/s00384-006-0259-6]
163. Nakagawa K, Tanaka K, Nojiri K, Kumamoto T, Takeda K, Ueda M, Endo I. The modifed Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases. Ann Surg Oncol 2014; 21: 1711-1718 [PMID: 24452408 DOI: 10.1245/s10434-013-3342-6]
164. Kobayashi T, Teruya M, Kishiki T, Endo D, Takenaka Y, Miki K, Kobayashi K, Morita K. Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival. Dig Surg 2010; 27: 285-290 [PMID: 20689289 DOI: 10.1159/000280021]
165. Kobayashi T, Kawakamil M, Hara Y, Shioiri S, Yasuno M, Teruya M, Kaminishi M. Combined evaluation of the Glasgow prognostic score and carcinoembryonic antigen concentration prior to hepatectomy predicts postoperative outcomes in patients with liver metastasis from colorectal cancer. Hepatogastroenterology 2014; 61: 1359-1362 [PMID: 25513096]
166. Chun YS, Vauthey JN, Boonsirikamchai P, Maru DM, Kopetz S, Palavecino M, Curley SA, Abdalla EK, Kaur H, Charnsangavej C, Loyer EM. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 2009; 302: 2338-2344 [PMID: 19952320 DOI: 10.1001/jama.2009.1755]
167. Rubbia-Brandt L, Giostra E, Brezault C, Roth AD, Andres A, Audard V, Sartoretti P, Dousset B, Majno PE, Soubrane O, Chaussade S, Mentha G, Terris B. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 2007; 18: 299-304 [PMID: 17060484 DOI: 10.1093/annonc/mdl386]
168. Nagashima I, Takada T, Matsuda K, Adachi M, Nagawa H, Muto T, Okinaga K. A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg 2004; 11: 79-83 [PMID: 15127268 DOI: 10.1007/s00534-002-0778-7]
169. Konopke R, Kersting S, Distler M, Dietrich J, Gastmeier J, Heller A, Kulisch E, Saeger HD. Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int 2009; 29: 89-102 [PMID: 18673436 DOI: 10.1111/j.1478-3231.2008.01845.x]
170. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247: 125-135 [PMID: 18156932 DOI: 10.1097/SLA.0b013e31815aa2c2]
171. Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC, Geller DA, Gayowski TJ, Fung JJ, Starzl TE. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 1999; 189: 291-299 [PMID: 10472930 DOI: 10.1016/s1072-7515(99)00089-7]
172. Zakaria S, Donohue JH, Que FG, Farnell MB, Schleck CD, Ilstrup DM, Nagorney DM. Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg 2007; 246: 183-191 [PMID: 17667495 DOI: 10.1097/SLA.0b013e3180603039]
173. Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, Gomez D, Lodge JP, Toogood GJ. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 2007; 246: 806-814 [PMID: 17968173 DOI: 10.1097/SLA.0b013e318142d964]
174. Ueno H, Mochizuki H, Hatsuse K, Hase K, Yamamoto T. Indicators for treatment strategies of colorectal liver metastases. Ann Surg 2000; 231: 59-66 [PMID: 10636103 DOI: 10.1097/0000 0658-200001000-00009]
175. Schindl M, Wigmore SJ, Currie EJ, Laengle F, Garden OJ. Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg 2005; 140: 183-189 [PMID: 15724001 DOI: 10.1001/archsurg.140.2.183]
176. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati P. Patterns of recurrence after resection of colorectal liver metastases: prediction by models of outcome analysis. World J Surg 2001; 25: 638-644 [PMID: 11369992 DOI: 10.1007/s002680020138]
177. Roberts KJ, White A, Cockbain A, Hodson J, Hidalgo E, Toogood GJ, Lodge JP. Performance of prognostic scores in predicting long-term outcome following resection of colorectal liver metastases. Br J Surg 2014; 101: 856-866 [PMID: 24817653 DOI: 10.1002/bjs.9471]
178. Hosmer DW, Lemeshow S. Introduction to the Logistic Regression Model. In: Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New Jersey: John Wiley & Sons, 2000: 1-30 [DOI: 10.1002/0471722146.ch1]
179. Pulitanò C, Castillo F, Aldrighetti L, Bodingbauer M, Parks RW, Ferla G, Wigmore SJ, Garden OJ. What defnes 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford) 2010; 12: 244-249 [PMID: 20590894 DOI: 10.1111/j.1477-2574.2010.00155.x]
180. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D'Angelica M. Actual 10-year survival after resection of colorectal liver metastases defnes cure. J Clin Oncol 2007; 25: 4575-4580 [PMID: 17925551 DOI: 10.1200/JCO.2007.11.0833]
181. Viganò L, Ferrero A, Lo Tesoriere R, Capussotti L. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 2008; 15: 2458-2464 [PMID: 18463927 DOI: 10.1245/s10434-008-9935-9]